Tag: Lefamulin

Approved by the FDA in 2019, lefamulin was the first systemic pleuromutilin antibiotic for human use. So, what is lefamulin used for? It is specifically prescribed to treat adults with community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms.

According to the Centers for Disease Control and Prevention (CDC), around one million people are hospitalized with community-acquired pneumonia in the United States each year, with 50,000 deaths from the disease. To combat this serious infection, new treatment options are crucial, which is where the pleuromutilin antibiotic Xenleta comes into play.